Trial Profile
ASP015K Pharmacokinetic Study: Evaluation of Drug-Drug Interaction Between ASP015K and Metformin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2020
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary) ; Metformin
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 16 May 2020 Results assessing the effect of peficitinib on metformin pharmacokinetics in vitro and in healthy volunteers published in the European Journal of Clinical Pharmacology
- 18 Jul 2016 Status changed from recruiting to completed.
- 01 Jun 2016 Status changed from not yet recruiting to recruiting.